查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954671

全球蒸气和过氧化氢灭菌用生物指示剂市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034）

Steam and Hydrogen Peroxide Biological Indicators Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 149 Pages | 商品交期: 请询问到货日

价格

蒸气和过氧化氢灭菌用生物指示剂市场成长驱动因素

2025年全球蒸汽和过氧化氢灭菌用生物指示剂市场规模为8.0376亿美元，2026年增长至8.6502亿美元，预计到2034年将达到16.4403亿美元。 2026年至2034年的复合年增长率为8.36%。 北美地区在全球市场中占领先地位，预计到2025年将占34.90%的市场占有率，这主要得益于严格的感染控制法规、外科手术数量的增加以及医疗和製药行业对灭菌监测方案的快速采用。美国市场预计到2030年将达到3.877亿美元，这主要受手术部位感染增加以及医院和牙科诊所对灭菌日益重视的推动。 市场概览与产品分析 生物指示剂（BI）可直接测量使用蒸气、过氧化氢、环氧乙烷和其他灭菌剂的灭菌过程的灭菌效果，从而确保可靠的监测。医疗机构、製药、生物技术和食品产业对灭菌的日益重视正在推动市场成长。强制要求预防污染的监管标准以及新产品的推出，进一步加速了生物指示剂在蒸气和过氧化氢灭菌中的应用。 依产品类型划分，自封式小瓶（SCBI）凭藉其高可靠性、易用性和快速出结果等优势，占最大的市场占有率。预计到2026年，自封式小瓶市占率将达到67.33%（价值5.824亿美元），主要得益于已开发医疗市场和新兴医疗市场对其应用的日益普及。孢子试纸条因其成本低廉且适用于小型诊所和医疗机构，占了第二大市场占有率。孢子悬浮指示剂也有应用，但市占率较小。

应用洞察

依应用领域划分，医疗机构预计到2026年将占全球市场72.26%的占有率，成为最大的细分市场，市场规模达6.251亿美元。医院感染（HAI）的增加和外科手术的增多，使得定期进行消毒监测至关重要。 製药和医疗器材製造商占第二大市场占有率，这凸显了生物指标在其生产流程中的重要性，因为严格的灭菌要求可以防止污染和产品召回。

新冠疫情的影响

新冠疫情加速了对灭菌和消毒监测产品的需求。医院、牙科诊所和製药公司加强了灭菌措施，以防止病毒和细菌引起的医院感染。例如，3M医疗解决方案部门2020年的收入成长了25.9%，反映了疫情期间对生物指标（BI）需求的成长。虽然疫情后的成长已趋于正常，但持续的外科手术和加强的感染控制方案意味着长期需求仍然强劲。

市场趋势

市场正在转向快速生物指标（Rapid BI），其比传统产品提供更快的检测结果。 传统指示剂需要 72 至 168 小时的培养时间，而快速生物指示剂可在数分钟内提供结果。监管机构的批准，例如美国 FDA 于 2020 年 1 月批准 Sterrad Velocity 生物指示剂，正在推动这一趋势，并扩大其在製药和医疗器材製造业的应用。 市场成长驱动因素：

外科手术数量的增加、慢性病盛行率的上升以及医疗保健成本的上涨，正在推动对无菌医疗器材的需求。根据世界卫生组织 (WHO) 统计，全球每年约进行 3.13 亿例手术，因此对监测设备（包括用于蒸汽和过氧化氢灭菌的生物指示剂）的需求显着增长。产品创新，例如 2020 年 12 月推出的 STERIS Spordex SCBI 安瓿，正在进一步促进市场成长。

限制因素：

生物指示剂 (BI) 的应用面临着来自酶指示剂等替代方案的竞争，后者俱有检测速度更快、使用更便捷、成本更低等优势。生物指示剂的高成本也限制了其应用，尤其是在发展中地区。例如，True Indicating LLC 的 Instant 20s 酶指示剂于 2021 年 12 月获得 FDA 批准，能够快速监测蒸汽灭菌过程，并对传统的商业智慧 (BI) 提出了挑战。

区域洞察

预计到 2025 年，北美将以 2.809 亿美元的市场规模引领市场，美国市场预计到 2026 年将达到 2.875 亿美元。欧洲市场呈现稳定成长态势，预计到 2026 年，英国市场规模将达到 3,340 万美元，德国将达到 5,380 万美元，这主要得益于人口老化和长期住院人数的增加。由于医药和医疗器材製造业的快速扩张，亚太地区预计将拥有最高的复合年增长率。到 2026 年，日本预计将达到 5,560 万美元，中国达到 7,230 万美元，印度达到 4,180 万美元。拉丁美洲和中东及非洲地区由于认知度较低，市场占有率较小。

主要公司与产业趋势

主要公司包括 3M、STERIS、ASP、Getinge、Mesa Labs、Tuttnauer、Bioquell 和 Terragene。主要趋势如下：

  • 2022 年 6 月：3M 的 Attest Rapid Readout BI 1295 汽化过氧化氢灭菌器获得批准。
  • 2022 年 3 月：Tuttnauer 收购了 Prestige Medical Ltd.，扩大了在特定国家的销售网络。
  • 2021年12月：Terragene与Keir Surgical Ltd.合作，开始提供蒸气灭菌的快速读数生物指示剂。
  • 2021年6月：STERIS收购了Cantel Medical LLC，将Crosstex BI产品线纳入其产品组合。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 定价、主要公司
  • 主要地区的灭菌指南
  • 关键趋势：併购、业务合作等
  • 新冠疫情对市场的影响

第五章 全球蒸气与过氧化氢灭菌生物指示剂市场分析：洞察与预测 （2021-2034）

  • 市场收入与规模（千单位）分析、洞察与预测：依产品类型划分
    • 独立式小瓶
    • 孢子条
    • 孢子悬浮液
  • 市场收入与规模（千单位）分析、洞察与预测：依应用领域划分
    • 製药和医疗器材製造商
    • 医疗机构
    • 其他
  • 市场收入与规模（千单位）分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美蒸气与过氧化氢灭菌用生物指示剂市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲蒸气与过氧化氢灭菌生物指示剂市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 义大利
    • 法国
    • 俄罗斯
    • 其他欧洲国家

第八章 亚太地区蒸气与过氧化氢灭菌生物指示剂市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 南亚国家韩国
    • 东南亚
    • 其他亚太地区

第九章 拉丁美洲蒸气与过氧化氢灭菌生物指示剂市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲国家

第10章 竞争分析

  • 全球市场占有率分析(2025年)
  • 企业简介
    • 3M
    • Mesa Labs, Inc.
    • Terragene
    • Ecolab
    • STERIS
    • Liofilchem S.r.l.
    • GKE-GmbH
    • Getinge
    • Tuttnauer
    • Etigam bv
    • Shanghai Fuze Medicine Equipment Co., Ltd.
    • Zhejiang TAILIN Bioengineering Co., LTD
    • SKAN AG
Product Code: FBI105204

Growth Factors of steam and hydrogen peroxide biological indicators Market

The global steam and hydrogen peroxide biological indicators market was valued at USD 803.76 million in 2025 and is projected to grow to USD 865.02 million in 2026, reaching USD 1,644.03 million by 2034, exhibiting a CAGR of 8.36% from 2026 to 2034. North America led the global market in 2025 with a 34.90% share, driven by stringent infection control regulations, growing surgical volumes, and rapid adoption of sterilization monitoring protocols across healthcare and pharmaceutical sectors. The U.S. market is expected to reach USD 387.7 million by 2030, owing to rising surgical site infections and increased focus on sterilization in hospitals and dental clinics.

Market Overview and Product Insights

Biological indicators (BIs) provide a direct measure of sterilization effectiveness, ensuring reliable monitoring in processes using steam, hydrogen peroxide, ethylene oxide, and other sterilizing agents. The increasing emphasis on sterilization in healthcare facilities, pharmaceutical, biotechnology, and food industries drives market growth. Regulatory standards enforcing contamination prevention, combined with new product launches, have further accelerated the adoption of steam and hydrogen peroxide biological indicators.

Among product types, self-contained vials (SCBIs) hold the largest share due to their high reliability, ease of use, and rapid results. In 2026, the self-contained vials segment accounted for 67.33% of the market, valued at USD 582.4 million, driven by higher adoption in both developed and emerging healthcare markets. Spore strips hold the second-largest share due to their lower cost and suitability for smaller clinics and healthcare facilities. Spore-suspension indicators are also used but represent a smaller market segment.

Application Insights

By application, healthcare facilities dominate, accounting for 72.26% of the global market in 2026, valued at USD 625.1 million. The rise in hospital-acquired infections (HAIs) and the growing number of surgical procedures necessitate routine sterilization monitoring. Pharmaceutical and medical device companies hold the second-largest share, as stringent sterilization requirements prevent contamination and product recalls, emphasizing the importance of biological indicators in production workflows.

COVID-19 Impact

The COVID-19 pandemic accelerated demand for sterilization and disinfectant monitoring products. Hospitals, dental clinics, and pharmaceutical companies increased sterilization measures to avoid viral or bacterial HAIs. For example, 3M's medical solutions division reported a 25.9% revenue increase in 2020, reflecting the heightened demand for BIs during the pandemic. While post-pandemic growth normalized, the long-term demand remains strong due to ongoing surgical procedures and heightened infection control protocols.

Market Trends

The market is witnessing a shift toward rapid biological indicators, offering faster results than conventional products. Traditional indicators require 72-168 hours for incubation, whereas rapid BIs provide results in minutes. Regulatory approvals, such as the U.S. FDA approval of the Sterrad Velocity Biological Indicator in January 2020, support this trend, increasing adoption across pharmaceutical and medical device manufacturing.

Market Growth Factors

Rising surgical volumes, increasing prevalence of chronic diseases, and higher healthcare expenditure drive the need for sterile medical instruments. Globally, approximately 313 million surgeries are performed annually, according to the WHO. This creates significant demand for monitoring devices, including steam and hydrogen peroxide biological indicators. Product innovations, such as STERIS Spordex SCBI Ampoules launched in December 2020, further enhance market growth.

Restraining Factors

The adoption of BIs faces competition from alternate solutions like enzyme indicators, which offer faster results, ease of use, and lower costs. The high cost of BIs also limits widespread adoption, particularly in developing regions. For instance, the FDA approved Instant 20s Enzymatic Indicator by True Indicating LLC in December 2021, capable of monitoring steam sterilization processes rapidly, challenging traditional BIs.

Regional Insights

North America led in 2025 with USD 280.9 million, and the U.S. market is projected at USD 287.5 million by 2026. Europe shows steady growth, with the UK reaching USD 33.4 million and Germany USD 53.8 million by 2026, driven by geriatric populations and longer hospital stays. Asia Pacific is expected to witness the highest CAGR due to rapid expansion of pharmaceutical and medical device manufacturing, with Japan at USD 55.6 million, China at USD 72.3 million, and India at USD 41.8 million by 2026. Latin America and the Middle East & Africa account for smaller shares due to lower awareness.

Key Players and Industry Developments

Major players include 3M, STERIS, ASP, Getinge, Mesa Labs, Tuttnauer, Bioquell, and Terragene. Notable developments include:

  • June 2022: 3M received approval for Attest Rapid Readout BI 1295 for vaporized hydrogen peroxide sterilization.
  • March 2022: Tuttnauer acquired Prestige Medical Ltd. to expand distribution in selected countries.
  • December 2021: Terragene partnered with Keir Surgical Ltd. to provide instant-read steam biological indicators.
  • June 2021: STERIS acquired Cantel Medical LLC, adding Crosstex BI products to its portfolio.

Conclusion

The steam and hydrogen peroxide biological indicators market is set for robust growth, expanding from USD 803.76 million in 2025 to USD 1,644.03 million by 2034, driven by increasing surgical procedures, stringent sterilization regulations, and technological innovations in rapid biological indicators. Despite challenges from alternate products and high costs, the ongoing focus on patient safety, HAIs prevention, and sterilization efficiency ensures strong market potential across healthcare and pharmaceutical sectors globally.

Segmentation By Product Type, By Application, and By Geography

By Product Type * Self-contained Vials

  • Spore Strips
  • Spore-suspension

By Application * Pharmaceutical & Medical Device Companies

  • Healthcare Facilities
  • Others

By Geography

North America (By Product Type, By Application, and By Country)

    • U.S.
    • Canada
  • Europe (By Product Type, By Application, and By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Application, and By Country/Sub-region)
    • Japan
    • China
    • India
    • Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Application, and By Country/Sub-region)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Application, and By Country/Sub-region)
    • Turkey
    • Saudi Arabia
    • U.A.E.
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Pricing, Key Players
  • 4.2. Guidelines for Sterilization: Key Region
  • 4.3. Key Mergers, Acquisitions, Partnerships, etc.
  • 4.4. Impact of COVID-19 on the Market

5. Global Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Self-contained Vials
    • 5.1.2. Spore Strips
    • 5.1.3. Spore Suspension
  • 5.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 5.2.1. Pharmaceutical and Medical Device Companies
    • 5.2.2. Healthcare Facilities
    • 5.2.3. Others
  • 5.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Self-contained Vials
    • 6.1.2. Spore Strips
    • 6.1.3. Spore Suspension
  • 6.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 6.2.1. Pharmaceutical and Medical Device Companies
    • 6.2.2. Healthcare Facilities
    • 6.2.3. Others
  • 6.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Self-contained Vials
    • 7.1.2. Spore Strips
    • 7.1.3. Spore Suspension
  • 7.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 7.2.1. Pharmaceutical and Medical Device Companies
    • 7.2.2. Healthcare Facilities
    • 7.2.3. Others
  • 7.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.3.1. Germany
    • 7.3.2. U.K.
    • 7.3.3. Italy
    • 7.3.4. France
    • 7.3.5. Russia
    • 7.3.6. Rest of Europe

8. Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Self-contained Vials
    • 8.1.2. Spore Strips
    • 8.1.3. Spore Suspension
  • 8.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 8.2.1. Pharmaceutical and Medical Device Companies
    • 8.2.2. Healthcare Facilities
    • 8.2.3. Others
  • 8.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. South Korea
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Self-contained Vials
    • 9.1.2. Spore Strips
    • 9.1.3. Spore Suspension
  • 9.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 9.2.1. Pharmaceutical and Medical Device Companies
    • 9.2.2. Healthcare Facilities
    • 9.2.3. Others
  • 9.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Argentina
    • 9.3.4. Rest of Latin America
  • 9.4. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 9.4.1. Self-contained Vials
    • 9.4.2. Spore Strips
    • 9.4.3. Spore Suspension
  • 9.5. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 9.5.1. Pharmaceutical and Medical Device Companies
    • 9.5.2. Healthcare Facilities
    • 9.5.3. Others
  • 9.6. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Turkey
    • 9.6.2. Saudi Arabia
    • 9.6.3. United Arab Emirates (U.A.E)
    • 9.6.4. Rest of Middle East & Africa

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
    • 10.2.1. 3M
      • 10.2.1.1. Overview,
      • 10.2.1.2. Products,
      • 10.2.1.3. SWOT Analysis,
      • 10.2.1.4. Recent Developments,
      • 10.2.1.5. Strategies,
      • 10.2.1.6. financials (Based on Availability)
    • 10.2.2. Mesa Labs, Inc.
      • 10.2.2.1. Overview,
      • 10.2.2.2. Products,
      • 10.2.2.3. SWOT Analysis,
      • 10.2.2.4. Recent Developments,
      • 10.2.2.5. Strategies,
      • 10.2.2.6. financials (Based on Availability)
    • 10.2.3. Terragene
      • 10.2.3.1. Overview,
      • 10.2.3.2. Products,
      • 10.2.3.3. SWOT Analysis,
      • 10.2.3.4. Recent Developments,
      • 10.2.3.5. Strategies,
      • 10.2.3.6. financials (Based on Availability)
    • 10.2.4. Ecolab
      • 10.2.4.1. Overview,
      • 10.2.4.2. Products,
      • 10.2.4.3. SWOT Analysis,
      • 10.2.4.4. Recent Developments,
      • 10.2.4.5. Strategies,
      • 10.2.4.6. financials (Based on Availability)
    • 10.2.5. STERIS
      • 10.2.5.1. Overview,
      • 10.2.5.2. Products,
      • 10.2.5.3. SWOT Analysis,
      • 10.2.5.4. Recent Developments,
      • 10.2.5.5. Strategies,
      • 10.2.5.6. financials (Based on Availability)
    • 10.2.6. Liofilchem S.r.l.
      • 10.2.6.1. Overview,
      • 10.2.6.2. Products,
      • 10.2.6.3. SWOT Analysis,
      • 10.2.6.4. Recent Developments,
      • 10.2.6.5. Strategies,
      • 10.2.6.6. financials (Based on Availability)
    • 10.2.7. GKE-GmbH
      • 10.2.7.1. Overview,
      • 10.2.7.2. Products,
      • 10.2.7.3. SWOT Analysis,
      • 10.2.7.4. Recent Developments,
      • 10.2.7.5. Strategies,
      • 10.2.7.6. financials (Based on Availability)
    • 10.2.8. Getinge
      • 10.2.8.1. Overview,
      • 10.2.8.2. Products,
      • 10.2.8.3. SWOT Analysis,
      • 10.2.8.4. Recent Developments,
      • 10.2.8.5. Strategies,
      • 10.2.8.6. financials (Based on Availability)
    • 10.2.9. Tuttnauer
      • 10.2.9.1. Overview,
      • 10.2.9.2. Products,
      • 10.2.9.3. SWOT Analysis,
      • 10.2.9.4. Recent Developments,
      • 10.2.9.5. Strategies,
      • 10.2.9.6. financials (Based on Availability)
    • 10.2.10. Etigam bv
      • 10.2.10.1. Overview,
      • 10.2.10.2. Products,
      • 10.2.10.3. SWOT Analysis,
      • 10.2.10.4. Recent Developments,
      • 10.2.10.5. Strategies,
      • 10.2.10.6. financials (Based on Availability)
    • 10.2.11. Shanghai Fuze Medicine Equipment Co., Ltd.
      • 10.2.11.1. Overview,
      • 10.2.11.2. Products,
      • 10.2.11.3. SWOT Analysis,
      • 10.2.11.4. Recent Developments,
      • 10.2.11.5. Strategies,
      • 10.2.11.6. financials (Based on Availability)
    • 10.2.12. Zhejiang TAILIN Bioengineering Co., LTD
      • 10.2.12.1. Overview,
      • 10.2.12.2. Products,
      • 10.2.12.3. SWOT Analysis,
      • 10.2.12.4. Recent Developments,
      • 10.2.12.5. Strategies,
      • 10.2.12.6. financials (Based on Availability)
    • 10.2.13. SKAN AG
      • 10.2.13.1. Overview,
      • 10.2.13.2. Products,
      • 10.2.13.3. SWOT Analysis,
      • 10.2.13.4. Recent Developments,
      • 10.2.13.5. Strategies,
      • 10.2.13.6. financials (Based on Availability)

List of Tables

  • Table 1: Global Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 3: Global Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 4: Global Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 5: Global Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Region, 2021-2034
  • Table 6: Global Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Region, 2021-2034
  • Table 7: North America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 8: North America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 9: North America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 10: North America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 11: North America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country, 2021-2034
  • Table 12: North America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country, 2021-2034
  • Table 13: Europe Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 15: Europe Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 16: Europe Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 17: Europe Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Europe Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 20: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 21: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 22: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 24: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 27: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 28: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 29: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 33: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 34: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Steam and Hydrogen Peroxide Biological Indicators Market Revenue Breakdown (USD Million, %) by Region, 2025 & 2034
  • Figure 2: Global Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Region, 2025 & 2034
  • Figure 5: North America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 6: North America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 7: North America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 8: North America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 9: North America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country, 2025 & 2034
  • Figure 10: North America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country, 2025
  • Figure 11: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 12: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 13: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 14: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 15: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 18: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 19: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 20: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 21: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 24: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 25: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 26: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 27: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 30: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 31: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 32: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 33: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Steam and Hydrogen Peroxide Biological Indicators Market Share (%), By Company, 2025